Mitochondria-targeted metallo-drugs against cancer: A current mechanistic perspective

Phan, 2020, The dormant cancer cell life cycle, Nature Reviews Cancer, 20, 398, 10.1038/s41568-020-0263-0 Falzone, 2018, Evolution of cancer pharmacological treatments at the turn of the third millennium, Frontiers in Pharmacology, 9, 1300, 10.3389/fphar.2018.01300 Tabish, 2021, Mitochondria-targeted graphene for advanced cancer therapeutics, Acta Biomaterialia, 129, 43, 10.1016/j.actbio.2021.04.054 Ward, 2019, Statin toxicity: mechanistic insights and clinical implications, Circulation Research, 124, 328, 10.1161/CIRCRESAHA.118.312782 Singh, 2019, Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles, Signal Transduction and Targeted Therapy, 4, 33, 10.1038/s41392-019-0068-3 Vyas, 2016, Mitochondria and cancer, Cell, 166, 555, 10.1016/j.cell.2016.07.002 Wallace, 2012, Mitochondria and cancer, Nature Reviews. Cancer, 12, 685, 10.1038/nrc3365 Warburg, 1956, On the origin of cancer cells, Science, 123, 309, 10.1126/science.123.3191.309 Warburg, 1956, On respiratory impairment in cancer cells, Science, 124, 269, 10.1126/science.124.3215.269 Zinovkin, 2023, Current perspectives of mitochondria-targeted antioxidants in cancer prevention and treatment, Frontiers in Cell and Development Biology, 11, 1048177, 10.3389/fcell.2023.1048177 Mukherjee, 2023, Targeting mitochondria as a potential therapeutic strategy against chemoresistance in cancer, Biomedicine & Pharmacotherapy, 160, 10.1016/j.biopha.2023.114398 Sullivan, 2014, Mitochondrial reactive oxygen species and cancer, Cancer Metab., 2, 1, 10.1186/2049-3002-2-17 Paprocka, 2022, Latest developments in metal complexes as anticancer agents, Coordination Chemistry Reviews, 452, 10.1016/j.ccr.2021.214307 Gasser, 2011, Organometallic anticancer compounds, Journal of Medicinal Chemistry, 54, 3, 10.1021/jm100020w Parveen, 2019, Development and future prospects of selective organometallic compounds as anticancer drug candidates exhibiting novel modes of action, European Journal of Medicinal Chemistry, 175, 269, 10.1016/j.ejmech.2019.04.062 Oun, 2018, The side effects of platinum-based chemotherapy drugs: a review for chemists, Dalton Transactions, 47, 6645, 10.1039/C8DT00838H Astolfi, 2013, Correlation of adverse effects of cisplatin administration in patients affected by solid tumours: A retrospective evaluation, Oncology Reports, 29, 1285, 10.3892/or.2013.2279 Olelewe, 2023, Mitochondria as a target of third row transition metal-based anticancer complexes, Current Opinion in Chemical Biology, 72, 10.1016/j.cbpa.2022.102235 Erxleben, 2019, Mitochondria-targeting anticancer metal complexes, Current Medicinal Chemistry, 26, 694, 10.2174/0929867325666180307112029 Javadov, 2020, Mitochondria in health and diseases, Cells, 9, 1177, 10.3390/cells9051177 Ilmarinen-Salo, 2012, Nitric oxide-induced eosinophil apoptosis is dependent on mitochondrial permeability transition (mPT), JNK and oxidative stress: apoptosis is preceded but not mediated by early mPT-dependent JNK activation, Respiratory Research, 13, 1 Warenius, 2023, the essential molecular requirements for the transformation of normal cells into established cancer cells, with implications for a novel anti‐cancer agent, Cancer Reports, 6, 10.1002/cnr2.1844 Pistritto, 2016, Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies, Aging (Albany NY), 8, 603, 10.18632/aging.100934 A.K. Wani, N. Akhtar, T.u.G. Mir, R. Singh, P.K. Jha, S.K. Mallik, S. Sinha, S.K. Tripathi, A. Jain, A. Jha, Targeting apoptotic pathway of cancer cells with phytochemicals and plant-based nanomaterials, Biomolecules 13 (2023) 194. A.M. Strohecker, J.Y. Guo, G. Karsli-Uzunbas, S.M. Price, G.J. Chen, R. Mathew, M. McMahon, E. White, Autophagy sustains mitochondrial glutamine metabolism and growth of Braf V600E–driven lung tumors, Cancer Discov. 3 (2013) 1272-1285. Carracedo, 2013, Cancer metabolism: fatty acid oxidation in the limelight, Nature Reviews. Cancer, 13, 227, 10.1038/nrc3483 LeBleu, 2014, PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis, Nature Cell Biology, 16, 992, 10.1038/ncb3039 Halestrap, 2010, A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection, Biochemical Society Transactions, 38, 841, 10.1042/BST0380841 T.T. Vellinga, T. Borovski, V.C. de Boer, S. Fatrai, S. van Schelven, K. Trumpi, A. Verheem, N. Snoeren, B.L. Emmink, J. Koster, SIRT1/PGC1α-dependent increase in oxidative phosphorylation supports chemotherapy resistance of colon cancer, Clin. Cancer Res. 21 (2015) 2870-2879. Haq, 2013, Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF, Cancer Cell, 23, 302, 10.1016/j.ccr.2013.02.003 Dhanasekaran, 2020, Emerging insights into mitochondria-specific targeting and drug delivering strategies: Recent milestones and therapeutic implications, saudi, Journal of Biological Sciences, 27, 3581 D'Souza, 2011, Approaches for targeting mitochondria in cancer therapy, Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids, 1807, 689, 10.1016/j.bbabio.2010.08.008 Gao, 2021, Mitochondria-targeted nanomedicine for enhanced efficacy of cancer therapy, Frontiers in Bioengineering and Biotechnology, 9, 10.3389/fbioe.2021.720508 Rin Jean, 2014, Molecular vehicles for mitochondrial chemical biology and drug delivery, ACS Chemical Biology, 9, 323, 10.1021/cb400821p Lee, 2015, Metabolic interplay between glycolysis and mitochondrial oxidation: the reverse warburg effect and its therapeutic implication, World Journal of Biological Chemistry, 6, 148, 10.4331/wjbc.v6.i3.148 C.A. Schmidt Prescription drugs and mitochondrial metabolism Biosci. Rep. 42 2022 BSR20211813. Dong, 2020, Mitocans revisited: mitochondrial targeting as efficient anti-cancer therapy, International Journal of Molecular Sciences, 21, 7941, 10.3390/ijms21217941 Martínez-Reyes, 2020, Mitochondrial TCA cycle metabolites control physiology and disease, Nature Communications, 11, 102, 10.1038/s41467-019-13668-3 Musicco, 2023, Mitochondria deregulations in cancer offer several potential targets of therapeutic interventions, International Journal of Molecular Sciences, 24, 10420, 10.3390/ijms241310420 Zhao, 2023, cancer metabolism: the role of ROS in DNA damage and induction of apoptosis in cancer cells, Metabolites, 13, 796, 10.3390/metabo13070796 Veselov, 2022, Targeted delivery methods for anticancer drugs, Cancers, 14, 622, 10.3390/cancers14030622 Liou, 2010, Reactive oxygen species in cancer, Free Radical Research, 44, 479, 10.3109/10715761003667554 Redza-Dutordoir, 2016, Activation of apoptosis signalling pathways by reactive oxygen species, Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids, 1863, 2977, 10.1016/j.bbamcr.2016.09.012 Li, 2015, Phosphorescent iridium (III)-bis-N-heterocyclic carbene complexes as mitochondria-targeted theranostic and photodynamic anticancer agents, Biomaterials, 39, 95, 10.1016/j.biomaterials.2014.10.070 Sudheesh, 2018, A cyclometalated IrIII complex as a Lysosome-Targeted photodynamic therapeutic agent for integrated imaging and therapy in cancer cells, Chemistry—a European Journal, 24, 10999, 10.1002/chem.201801918 Nam, 2016, Endoplasmic reticulum-localized iridium (III) complexes as efficient photodynamic therapy agents via protein modifications, Journal of the American Chemical Society, 138, 10968, 10.1021/jacs.6b05302 Chen, 2021, Cyclometalated iridium (III) complexes as mitochondria-targeted anticancer and antibacterial agents to induce both autophagy and apoptosis, Journal of Inorganic Biochemistry, 219, 10.1016/j.jinorgbio.2021.111450 J. Chen, X. Guo, D. Li, H. Tang, J. Gao, W. Yu, X. Zhu, Z. Sun, Z. Huang, L. Chen, Mitochondria-targeted cyclometalated iridium-β-carboline complexes as potent non-small cell lung cancer therapeutic agents, Metallomics 15 (2023) mfad035. Li, 2019, Mitochondria-targeting cyclometalated iridium (III) complexes for tumor hypoxic imaging and therapy, Inorganic Chemistry Frontiers, 6, 1003, 10.1039/C9QI00081J Ye, 2016, Coumarin-appended phosphorescent cyclometalated iridium (iii) complexes as mitochondria-targeted theranostic anticancer agents, Dalton Transactions, 45, 13042, 10.1039/C6DT00601A Cao, 2017, Targeting cancer cell metabolism with mitochondria-immobilized phosphorescent cyclometalated iridium (III) complexes, Chemical Science, 8, 631, 10.1039/C6SC02901A Zhang, 2018, Photoinduced anticancer activity studies of iridium (III) complexes targeting mitochondria and tubules, European Journal of Medicinal Chemistry, 151, 568, 10.1016/j.ejmech.2018.04.013 Southam, 2017, The microbiology of ruthenium complexes, Advances in Microbial Physiology, 71, 1, 10.1016/bs.ampbs.2017.03.001 Thota, 2016, Anticancer ruthenium complexes in drug discovery and medicinal chemistry, Mini Reviews in Medicinal Chemistry, 16, 771, 10.2174/138955751610160503003405 Duan, 2009, Isolated seven-coordinate ru (IV) dimer complex with [HOHOH]− bridging ligand as an intermediate for catalytic water oxidation, Journal of the American Chemical Society, 131, 10397, 10.1021/ja9034686 Lin, 2018, Applications of ruthenium complex in tumor diagnosis and therapy, Frontiers in Pharmacology, 9, 1323, 10.3389/fphar.2018.01323 Xu, 2018, Mitochondria-targeted half-sandwich ruthenium II diimine complexes: Anticancer and antimetastasis via ROS-mediated signalling, Inorganic Chemistry Frontiers, 5, 2100, 10.1039/C8QI00476E Yang, 2023, Naphthalene Diimide-Functionalized Half-Sandwich ru (II) complexes as Mitochondria-Targeted anticancer and antimetastatic agents, Inorganic Chemistry, 62, 9649, 10.1021/acs.inorgchem.3c01125 Liu, 2015, Ruthenium (II) polypyridyl complexes as mitochondria-targeted two-photon photodynamic anticancer agents, Biomaterials, 56, 140, 10.1016/j.biomaterials.2015.04.002 Zheng, 2018, Photodamaging of mitochondrial DNA to overcome cisplatin resistance by a RuII–PtII bimetallic complex, Chemistry—a European Journal, 24, 18971, 10.1002/chem.201803630 Sahu, 2023, Ruthenium (II)-Dithiocarbazates as anticancer agents: Synthesis, solution behavior, and Mitochondria-Targeted apoptotic cell death, Chemistry—a European Journal, 29, e202202694, 10.1002/chem.202202694 Muhammad, 2020, Mitochondria-targeting monofunctional platinum (ii)–lonidamine conjugates for cancer cell de-energization, Inorganic Chemistry Frontiers, 7, 4010, 10.1039/D0QI01028F Li, 2017, Mitochondria-targeted platinum (ii) complexes: dual inhibitory activities on tumor cell proliferation and migration/invasion via intracellular trafficking of β-catenin, Metallomics, 9, 726, 10.1039/C6MT00188B Wang, 2018, Mitochondria-targeted platinum (II) complexes induce apoptosis-dependent autophagic cell death mediated by ER-stress in A549 cancer cells, European Journal of Medicinal Chemistry, 155, 639, 10.1016/j.ejmech.2018.06.018 Zhu, 2019, Mitochondrion-targeted platinum complexes suppressing lung cancer through multiple pathways involving energy metabolism, Chemical Science, 10, 3089, 10.1039/C8SC04871A Jin, 2018, Impact of mitochondrion-targeting group on the reactivity and cytostatic pathway of platinum (IV) complexes, Inorganic Chemistry, 57, 11135, 10.1021/acs.inorgchem.8b01707 Su, 2022, Mitochondria-targeted pt (IV) prodrugs conjugated with an aggregation-induced emission luminogen against breast cancer cells by dual modulation of apoptosis and autophagy inhibition, Journal of Inorganic Biochemistry, 226, 10.1016/j.jinorgbio.2021.111653 Peng, 2021, Mitochondria-targeted cyclometalated rhodium (iii) complexes: synthesis, characterization and anticancer research, Dalton Transactions, 50, 9068, 10.1039/D1DT01053K Peng, 2021, Mitochondrial targeted rhodium (III) complexes: Synthesis, characterized and antitumor mechanism investigation, Journal of Inorganic Biochemistry, 218, 10.1016/j.jinorgbio.2021.111400 Pérez-Arnaiz, 2018, Thiabendazole-based rh (III) and ir (III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity, European Journal of Medicinal Chemistry, 157, 279, 10.1016/j.ejmech.2018.07.065 Yeo, 2018, Gold-based medicine: a paradigm shift in anti-cancer therapy?, Molecules, 23, 1410, 10.3390/molecules23061410 Arojojoye, 2020, Synthesis, characterization, and antiproliferative activity of novel chiral [QuinoxP* AuCl2]+ complexes, Molecules, 25, 5735, 10.3390/molecules25235735 Ofori, 2021, Gold-Based pharmacophore inhibits intracellular MYC protein, Chemistry—a European Journal, 27, 4168, 10.1002/chem.202004962 Kim, 2021, Anticancer gold (III)-bisphosphine complex alters the mitochondrial electron transport chain to induce in vivo tumor inhibition, Chemical Science, 12, 7467, 10.1039/D1SC01418H Olelewe, 2022, Gold (III)-P-chirogenic complex induces mitochondrial dysfunction in triple-negative breast cancer, Iscience, 25, 104340, 10.1016/j.isci.2022.104340 Babak, 2021, Interfering with metabolic profile of Triple-Negative breast cancers using rationally designed metformin prodrugs, Angewandte Chemie (International Ed. in English), 60, 13405, 10.1002/anie.202102266 Rackham, 2007, A gold (I) phosphine complex selectively induces apoptosis in breast cancer cells: implications for anticancer therapeutics targeted to mitochondria, Biochemical Pharmacology, 74, 992, 10.1016/j.bcp.2007.07.022 Mertens, 2021, Synthetic control of mitochondrial dynamics: developing three-coordinate au (I) probes for perturbation of mitochondria structure and function, JACS au, 1, 439, 10.1021/jacsau.1c00051 Hickey, 2008, Mitochondria-targeted chemotherapeutics: the rational design of gold (I) n-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols, Journal of the American Chemical Society, 130, 12570, 10.1021/ja804027j Marker, 2020, Exploring the in vivo and in vitro anticancer activity of rhenium isonitrile complexes, Inorganic Chemistry, 59, 10285, 10.1021/acs.inorgchem.0c01442 Konkankit, 2019, In vivo anticancer activity of a rhenium (I) tricarbonyl complex, ACS Medicinal Chemistry Letters, 10, 822, 10.1021/acsmedchemlett.9b00128 Pan, 2020, Recoding the cancer epigenome by intervening in metabolism and iron homeostasis with Mitochondria-Targeted rhenium (I) complexes, Angewandte Chemie (International Ed. in English), 59, 18755, 10.1002/anie.202008624 Wang, 2019, Mitochondria-accumulating rhenium (I) tricarbonyl complexes induce cell death via irreversible oxidative stress and glutathione metabolism disturbance, ACS Applied Materials & Interfaces, 11, 13123, 10.1021/acsami.9b01057 He, 2022, Rhenium–guanidine complex as photosensitizer: trigger HeLa cell apoptosis through death receptor-mediated, mitochondria-mediated, and cell cycle arrest pathways, Metallomics, 14, mfac008, 10.1093/mtomcs/mfac008 Ji, 2023, Potential of copper and copper compounds for anticancer applications, Pharmaceuticals, 16, 234, 10.3390/ph16020234 Molinaro, 2020, Copper complexes as anticancer agents targeting topoisomerases I and II, Cancers, 12, 2863, 10.3390/cancers12102863 Deka, 2017, Novel mitochondria targeted copper (II) complexes of ferrocenyl terpyridine and anticancer active 8-hydroxyquinolines showing remarkable cytotoxicity, DNA and protein binding affinity, Dalton Transactions, 46, 396, 10.1039/C6DT03660K Shao, 2019, TPP-related mitochondrial targeting copper (II) complex induces p53-dependent apoptosis in hepatoma cells through ROS-mediated activation of Drp1, Cell Communication and Signaling, 17, 1, 10.1186/s12964-019-0468-6 Zhou, 2014, A mitochondrion-targeting copper complex exhibits potent cytotoxicity against cisplatin-resistant tumor cells through multiple mechanisms of action, Chemical Science, 5, 2761, 10.1039/C4SC00384E Nagai, 2012, the oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells, Free Radical Biology & Medicine, 52, 2142, 10.1016/j.freeradbiomed.2012.03.017 Scalcon, 2023, Exploring the anticancer activity of Tamoxifen-Based metal complexes targeting mitochondria, Journal of Medicinal Chemistry, 66, 9823, 10.1021/acs.jmedchem.3c00617 Zhao, 2019, A novel tumor and mitochondria dual-targeted photosensitizer showing ultra-efficient photodynamic anticancer activities, Chem. Comm., 55, 866, 10.1039/C8CC09456J Sarkar, 2021, Mixed-ligand cobalt (III) complexes of a naturally occurring coumarin and phenanthroline bases as mitochondria-targeted dual-purpose photochemotherapeutics, Inorganic Chemistry, 60, 6649, 10.1021/acs.inorgchem.1c00444 Shumi, 2022, Metal complexes in Target-Specific anticancer therapy: Recent trends and challenges, Journal of Chemistry, 2022, 1, 10.1155/2022/9261683